In stable MS patients, stopping Ocrevus does not seem to increase the risk of disease activity or disability progression for ...

Grace Miller was a 24-year-old law school student when she was diagnosed with multiple sclerosis ...

A clinical trial in China testing ICP-538, a treatment candidate for MS and other autoimmune diseases, has dosed its first healthy volunteer.

RMAT designation is based on promising Phase 2 clinical data demonstrating NG01’s potential to reduce disability and ...

‘Active’ man diagnosed with MS at 26 after falling over on lads’ holiday in Ibiza - George Mckinty noticed the first sign of multiple sclerosis while at the gym in August 2021 ...

Fred D. Lublin, MD, discusses therapy sequencing, deescalation, health equity, and the future of multiple sclerosis (MS) care delivery. Effective multiple sclerosis (MS) treatment requires thinking ...

George Mckinty says he became concerned as he also suffered from vision problems in one eye.

The discovery could open up new ways for treating diseases such as MS by leveraging molecules that are already present in the human body.

IRVINGTON, VA, UNITED STATES, March 19, 2026 /EINPresswire.com/ — The Dermatology Education Foundation today announced the launch of the Access Granted(TM) Initiative, a compreh ...

Patients with multiple sclerosis (MS) who were receiving disease-modifying therapies were found to have rare occurrences of severe COVID-19 if they had received the vaccine, according to a study ...

A two-drug combination frequently used in anti-aging research causes brain damage in mice, report University of Connecticut researchers in the Proceedings of the National Academy of Sciences. The ...